2026 NPPES data Rheumatology Physician NPI 1982686135 M.D.,
Verify on CMS →

KARAMALI BANDEALY, M.D.,

Rheumatology Physician in KISSIMMEE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
303
Medicare Part D claims · 86 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

KARAMALI BANDEALY, M.D., filed 303 Medicare Part D claims in 2023 as a Rheumatology Physician in KISSIMMEE, Florida, prescribing 87% generic.

303
Part D claims, 2023
87%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KARAMALI BANDEALY, M.D.,'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

303 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

KARAMALI BANDEALY, M.D., practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KARAMALI BANDEALY, M.D.,?

Quality data not reported

NPI registry status

Active

Issued 11/15/2005

NPI 1982686135

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

303 85% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

Specialty distribution in Florida

How Rheumatology Physician compares to other specialties among Florida providers

Florida providers

Rheumatology Physician share within Florida

1. Rheumatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Rheumatology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Rheumatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Rheumatology Physician ABMS/AOA estimate

Est. board-certified rate (Rheumatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Rheumatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KARAMALI BANDEALY, M.D., appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D., credentials at 1020 W OAK ST, KISSIMMEE, FL, 34741, with a listed phone of (407) 870-1579. NPI 1982686135 was issued on 11/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BANDEALY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 303 prescription claims written by this provider, covering 86 Medicare beneficiaries and totaling roughly $102K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1020 W OAK ST
KISSIMMEE, FL 34741

Provider Details

NPI 1982686135
Specialty Rheumatology Physician
Credentials M.D.,
Gender Male
NPI Issued 11/15/2005

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KARAMALI BANDEALY, M.D.,. To verify KARAMALI BANDEALY, M.D.,'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KARAMALI BANDEALY, M.D., — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 303 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

303
Total Claims
$102K
Total Drug Cost
86
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
469
Total Day Supply
13,804
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$96K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
68.0 years
Avg HCC Risk Score
2.20
Gender Split
79% female / 21% male
Age Distribution
<65: 27, 65-74: 38, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KARAMALI BANDEALY, M.D., prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
53
Hydroxychloroquine Sulfate
27
Meloxicam
24
Prednisone
23
Baclofen
20
Misoprostol
19
Duloxetine Hcl
12
Tizanidine Hcl
12
Naproxen
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How KARAMALI BANDEALY, M.D., fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

KARAMALI BANDEALY, M.D.,'s 303 claims are below the specialty average of 2,054.

Nearby Rheumatology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BANDEALY.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KARAMALI BANDEALY, M.D.,'s specialty?
KARAMALI BANDEALY, M.D., specializes in Rheumatology Physician and practices in KISSIMMEE, Florida. Credentials: M.D.,.
How much does KARAMALI BANDEALY, M.D., prescribe under Medicare Part D?
In 2023, KARAMALI BANDEALY, M.D., wrote 303 Medicare Part D claims totaling $102K in drug costs for 86 beneficiaries.
Where is KARAMALI BANDEALY, M.D., located?
KARAMALI BANDEALY, M.D., is located at 1020 W OAK ST, KISSIMMEE, FL, 34741. Phone: (407) 870-1579.
What is KARAMALI BANDEALY, M.D.,'s NPI number?
KARAMALI BANDEALY, M.D.,'s National Provider Identifier (NPI) is 1982686135, issued on 11/15/2005.
Does KARAMALI BANDEALY, M.D., prescribe more brand-name or generic drugs?
KARAMALI BANDEALY, M.D.,'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $96K in brand drug costs.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does KARAMALI BANDEALY, M.D., prescribe most often?
Based on 2023 Medicare Part D data, KARAMALI BANDEALY, M.D.,'s most frequently prescribed drugs include Gabapentin, Hydroxychloroquine Sulfate, Meloxicam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KARAMALI BANDEALY, M.D., accept Medicare?
KARAMALI BANDEALY, M.D., appears in CMS Medicare data with 303 Part D claims and 86 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KARAMALI BANDEALY, M.D.,'s credentials?
KARAMALI BANDEALY, M.D.,'s NPI is 1982686135 with credentials M.D.,. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology